Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice

Maureen A. Shaw, Keith W. Kombrinck, Kathryn E. McElhinney, David R. Sweet, Matthew J. Flick, Joseph S. Palumbo, Mei Cheng, Naomi L. Esmon, Charles T. Esmon, Alexander Brill, Denisa D. Wagner, Jay L. Degen, Eric S. Mullins

Blood (2016) 128 (5): 721–731.

https://doi.org/10.1182/blood-2015-11-680280

Published: 2016

Includes: Multimedia, Supplemental data

Journal Articles

Plasmin(ogen) Deficiency Is Protective Against The Development Of Neuroinflammatory Pathologies and Paralysis In a Murine Model Of Multiple Sclerosis

Eric S. Mullins, MD, Maureen A Shaw, MS, Kathryn E McElhinney, Keith W. Kombrinck, MS, Jay L. Degen, PhD

Blood (2013) 122 (21): 1090.

https://doi.org/10.1182/blood.V122.21.1090.1090

Published: 2013

Journal Articles

Mice with Genetic Modifications in Prothrombin Limiting Activation Cleavage Events to Meizothrombin Survive to Adulthood, but Exhibit Alterations in Hemostasis and Thrombus Formation

Eric S. Mullins, MD, Maureen A. Shaw, M.S, Kathryn E. McElhinney, Keith W. Kombrinck, M.S., Matthew J. Flick, PhD, Alexander Brill, MD, PhD, Denisa D. Wagner, PhD, Jay L. Degen, PhD

Blood (2012) 120 (21): 496.

https://doi.org/10.1182/blood.V120.21.496.496

Published: 2012

Journal Articles

Plasminogen Mediates Both Positive and Negative Effects on Disease Severity in a Mouse Model of TNFα-Driven Arthritis

Harini Raghu, Malinda D. Frederick, Alice Jone, Kathryn E. Talmage, Keith W. Kombrinck, Matthew J. Flick, PhD

Blood (2011) 118 (21): 854.

https://doi.org/10.1182/blood.V118.21.854.854

Published: 2011

Journal Articles

Factor XIII Deficiency Improves Motor Function in Mice Challenged with Experimental Autoimmune Encephalomyelitis, An Established Model of Multiple Sclerosis

Eric S. Mullins, MD, Kathryn E. Talmage, Keith W. Kombrinck, Whitney M Miller, Joseph S. Palumbo, MD, Jay L. Degen, PhD

Blood (2011) 118 (21): 858.

https://doi.org/10.1182/blood.V118.21.858.858

Published: 2011

Journal Articles

The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A

Matthew J. Flick, Anil K. Chauhan, Malinda Frederick, Kathryn E. Talmage, Keith W. Kombrinck, Whitney Miller, Eric S. Mullins, Joseph S. Palumbo, Xunzhen Zheng, Naomi L. Esmon, Charles T. Esmon, Sherry Thornton, Ann Becker, Leslie A. Pelc, Enrico Di Cera, Denisa D. Wagner, Jay L. Degen

Blood (2011) 117 (23): 6326–6337.

https://doi.org/10.1182/blood-2010-08-304915

Published: 2011

Journal Articles

Host Fibrinogen and the S. Aureus -Encoded Procoagulant Vwbp Are Context-Dependent Determinants of Bacterial Virulence.

Joni M Prasad, Xinli Du, MD, PhD, Eric S. Mullins, MD, Senad Divanovic, PhD, Kathryn E Talmage, Keith W Kombrinck, Alice G Cheng, Olaf Schneewind, MD, PhD, Matthew J. Flick, PhD, Jay L. Degen, PhD

Blood (2010) 116 (21): 1152.

https://doi.org/10.1182/blood.V116.21.1152.1152

Published: 2010

Journal Articles

Host Prothrombin and Fibrinogen Support S. Aureus Virulence In the Context of Acute Bacteremia

Matthew J. Flick, PhD, Xinli Du, PhD, Leslie Fausnacht, Harini Raghu, Kathryn E Talmage, Keith W Kombrinck, Elizabeth A. Blevins, Eric S. Mullins, MD, Joseph S. Palumbo, MD, Jay L. Degen, PhD

Blood (2010) 116 (21): 821.

https://doi.org/10.1182/blood.V116.21.821.821

Published: 2010

Journal Articles

Transfusion Related Acute Lung Injury (TRALI) Is Ameliorated by Genetic Elimination of Fibrin(ogen) in Mice.

Eric S. Mullins, MD, Kathryn E. Talmage, Matthew Flick, PhD, Keith W. Kombrinck, Richard T Strait, MD, Jay L Degen, PhD

Blood (2009) 114 (22): 3189.

https://doi.org/10.1182/blood.V114.22.3189.3189

Published: 2009

Journal Articles

Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain

Eric S. Mullins, Keith W. Kombrinck, Kathryn E. Talmage, Maureen A. Shaw, David P. Witte, Joni M. Ullman, Sandra J. Degen, William Sun, Matthew J. Flick, Jay L. Degen

Blood (2009) 113 (3): 696–704.

https://doi.org/10.1182/blood-2008-07-169003

Published: 2009

Includes: Supplemental data

Journal Articles

Genetic Elimination of Prothrombin in Adult Mice Results in Fatal Spontaneous Hemorrhage in the Heart and Central Nervous System

Eric S. Mullins, MD, Keith W. Kombrinck, Kathryn E. Talmage, Maureen A. Shaw, David P. Witte, Joni M. Ullman, Sandra J. Degen, William Sun, Matthew Flick, PhD, Jay Degen

Blood (2008) 112 (11): 395.

https://doi.org/10.1182/blood.V112.11.395.395

Published: 2008

Journal Articles

Reduction of Prothrombin in Mice Carrying a Conditional Knockout Allele Attenuates the Development of Paralysis Associated with Experimental Encephalitis.

Eric S. Mullins, MD, Keith W. Kombrinck, MS, Matthew J. Flick, PhD, Maureen A. Shaw, BS, William Sun, PhD, Sandra J. Degen, PhD, Katerina Akassoglou, PhD, Jay L. Degen, PhD

Blood (2007) 110 (11): 407.

https://doi.org/10.1182/blood.V110.11.407.407

Published: 2007

Journal Articles

Tumor cell–associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell–dependent and–independent mechanisms

Joseph S. Palumbo, Kathryn E. Talmage, Jessica V. Massari, Christine M. La Jeunesse, Matthew J. Flick, Keith W. Kombrinck, Zhiwei Hu, Kelley A. Barney, Jay L. Degen

Blood (2007) 110 (1): 133–141.

https://doi.org/10.1182/blood-2007-01-065995

Published: 2007

Journal Articles

Tumor Cell-Associated Tissue Factor Supports Metastatic Potential through Both NK Cell-Dependent and -Independent Mechanisms.

Joseph Palumbo, MD, Kelley A. Barney, Matthew J. Flick, PhD, Kathryn E. Talmage, Keith W. Kombrinck, Zhiwei Hu, PhD, Christine M. La Jeunesse, Jay L. Degen, PhD

Blood (2006) 108 (11): 66.

https://doi.org/10.1182/blood.V108.11.66.66

Published: 2006

Journal Articles

Conditional Disruption of the Murine Prothrombin Gene.

Eric S. Mullins, MD, Matthew J. Flick, PhD, Keith W. Kombrinck, Sandra J. Degen, PhD, William Sun, PhD, Jay L. Degen, PhD

Blood (2006) 108 (11): 1600.

https://doi.org/10.1182/blood.V108.11.1600.1600

Published: 2006

Journal Articles

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells

Joseph S. Palumbo, Kathryn E. Talmage, Jessica V. Massari, Christine M. La Jeunesse, Matthew J. Flick, Keith W. Kombrinck, Markéta Jirousková, Jay L. Degen

Blood (2005) 105 (1): 178–185.

https://doi.org/10.1182/blood-2004-06-2272

Published: 2005

Journal Articles

Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells

Joseph S. Palumbo, Keith W. Kombrinck, Angela F. Drew, Timothy S. Grimes, John H. Kiser, Jay L. Degen, Thomas H. Bugge

Blood (2000) 96 (10): 3302–3309.

https://doi.org/10.1182/blood.V96.10.3302

Published: 2000

Journal Articles

Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice

Thomas H. Bugge, Keith W. Kombrinck, Qing Xiao, Kenn Holmbäck, Cynthia C. Daugherty, Dave P. Witte, Jay L. Degen

Blood (1997) 90 (11): 4522–4531.

https://doi.org/10.1182/blood.V90.11.4522

Published: 1997

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Limiting prothrombin activation to meizothrombin is compatible with survival but significantly alters hemostasis in mice

Plasmin(ogen) Deficiency Is Protective Against The Development Of Neuroinflammatory Pathologies and Paralysis In a Murine Model Of Multiple Sclerosis

Mice with Genetic Modifications in Prothrombin Limiting Activation Cleavage Events to Meizothrombin Survive to Adulthood, but Exhibit Alterations in Hemostasis and Thrombus Formation

Plasminogen Mediates Both Positive and Negative Effects on Disease Severity in a Mouse Model of TNFα-Driven Arthritis

Factor XIII Deficiency Improves Motor Function in Mice Challenged with Experimental Autoimmune Encephalomyelitis, An Established Model of Multiple Sclerosis

The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A

Host Fibrinogen and the S. Aureus -Encoded Procoagulant Vwbp Are Context-Dependent Determinants of Bacterial Virulence.

Host Prothrombin and Fibrinogen Support S. Aureus Virulence In the Context of Acute Bacteremia

Transfusion Related Acute Lung Injury (TRALI) Is Ameliorated by Genetic Elimination of Fibrin(ogen) in Mice.

Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain

Genetic Elimination of Prothrombin in Adult Mice Results in Fatal Spontaneous Hemorrhage in the Heart and Central Nervous System

Reduction of Prothrombin in Mice Carrying a Conditional Knockout Allele Attenuates the Development of Paralysis Associated with Experimental Encephalitis.

Tumor cell–associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell–dependent and–independent mechanisms

Tumor Cell-Associated Tissue Factor Supports Metastatic Potential through Both NK Cell-Dependent and -Independent Mechanisms.

Conditional Disruption of the Murine Prothrombin Gene.

Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cells

Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells

Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only